Table 1

Patient demographics and baseline characteristics

CharacteristicsAdvanced CSCC (group 4, n=63)
Age, median (range), years74 (23–94)
Male sex, n (%)53 (84)
ECOG performance status, n (%)
025 (40)
138 (60)
Extent of disease, n (%)
Metastatic39 (62)
Locally advanced24 (38)
Prior cancer-related radiotherapy, n (%)38 (60)
Number of cancer-related systemic therapy regimens at baseline, n (%)
054 (86)
17 (11)
22 (3)
  • Data cut-off date: 20 April 2022.

  • CSCC, cutaneous squamous cell carcinoma; ECOG, Eastern Cooperative Oncology Group.